When we wrote up the updated myocarditis paper1, we had an idea to include examples of individuals who had succumbed to myocarditis many months after their last injection of COVID-19 injectable product, as per their reports to VAERS. In both cases included our paper, the product was Pfizer. As you can see in Figure 1 below, a 15-year-old boy had a diagnosis of idiopathic myocarditis that resulted in death 358 days after his first, and last, Pfizer injection.
This is shocking enough, and these are only two examples. These late occurrences of myocardial incidents left me thinking about the long-term effects of these modified mRNA COVID-19 products.
I was more recently prompted to examine clot-related adverse events (AEs) in VAERS, since the lipid nanoparticles (LNPs) are suspected to be – along with the spike protein – a root cause of hemagglutination. I gave a talk about all things LNP to Doctors for COVID Ethics last year, and you can watch that here. I think they disrupt the zeta potential of red blood cells, as does the spike protein.23
Hellbound and Down 